Business Description
MeVis Medical Solutions AG
ISIN : DE000A0LBFE4
Description
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | 110.74 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.33 | |||||
| Beneish M-Score | -2.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.4 | |||||
| 3-Year EBITDA Growth Rate | -4.7 | |||||
| 3-Year EPS without NRI Growth Rate | -6.4 | |||||
| 3-Year FCF Growth Rate | 27.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.32 | |||||
| 9-Day RSI | 59.74 | |||||
| 14-Day RSI | 58.77 | |||||
| 6-1 Month Momentum % | -3.94 | |||||
| 12-1 Month Momentum % | -3.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.8 | |||||
| Cash Ratio | 1.06 | |||||
| Days Sales Outstanding | 48.89 | |||||
| Days Payable | 37.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.77 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 3.77 | |||||
| 5-Year Yield-on-Cost % | 3.77 | |||||
| Shareholder Yield % | 3.77 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.24 | |||||
| Operating Margin % | 26.99 | |||||
| Net Margin % | 32.6 | |||||
| FCF Margin % | 32.73 | |||||
| ROE % | 32.27 | |||||
| ROA % | 22.25 | |||||
| ROIC % | 25.09 | |||||
| 3-Year ROIIC % | -2979.54 | |||||
| ROC (Joel Greenblatt) % | 2387.42 | |||||
| ROCE % | 23.76 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.97 | |||||
| PE Ratio without NRI | 7.97 | |||||
| Shiller PE Ratio | 6.7 | |||||
| PS Ratio | 2.6 | |||||
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 2.57 | |||||
| Price-to-Free-Cash-Flow | 7.94 | |||||
| Price-to-Operating-Cash-Flow | 7.84 | |||||
| EV-to-EBIT | 8.31 | |||||
| EV-to-EBITDA | 8.13 | |||||
| EV-to-Revenue | 2.32 | |||||
| EV-to-FCF | 7.1 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Graham-Number | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 45.82 | |||||
| Earnings Yield (Greenblatt) % | 12.03 | |||||
| FCF Yield % | 12.59 | |||||
| Forward Rate of Return (Yacktman) % | 5.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MeVis Medical Solutions AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 17.644 | ||
| EPS (TTM) (€) | 3.16 | ||
| Beta | 0.24 | ||
| Volatility % | 15.56 | ||
| 14-Day RSI | 58.77 | ||
| 14-Day ATR (€) | 0.209433 | ||
| 20-Day SMA (€) | 24.88 | ||
| 12-1 Month Momentum % | -3.17 | ||
| 52-Week Range (€) | 22.8 - 26.8 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MeVis Medical Solutions AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MeVis Medical Solutions AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
MeVis Medical Solutions AG Frequently Asked Questions
What is MeVis Medical Solutions AG(XTER:M3V)'s stock price today?
The current price of XTER:M3V is €25.20. The 52 week high of XTER:M3V is €26.80 and 52 week low is €22.80.
When is next earnings date of MeVis Medical Solutions AG(XTER:M3V)?
The next earnings date of MeVis Medical Solutions AG(XTER:M3V) is .
Does MeVis Medical Solutions AG(XTER:M3V) pay dividends? If so, how much?
The Dividend Yield %  of MeVis Medical Solutions AG(XTER:M3V) is 3.77% (As of Today), Highest Dividend Payout Ratio of MeVis Medical Solutions AG(XTER:M3V) was 0.3. The lowest was 0.01. And the median was 0.22. The  Forward Dividend Yield % of MeVis Medical Solutions AG(XTER:M3V) is 3.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers